← Evidence map

ArticleAmerican journal of nephrology2026

Prognostic Relevance of Erythropoiesis-Stimulating Agent Dose Requirements in PIVOTAL and Its Implications for the Potential Mechanisms of Intravenous Iron Benefit in Maintenance Haemodialysis Patients.

Benjamin A Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Prognostic Relevance of Erythropoiesis-Stimulating Agent Dose Requirements in PIVOTAL and Its Implications for the Potential Mechanisms of Intravenous Iron Benefit in Maintenance Haemodialysis Patients. | OpenQuestion